Valeant's dose of reality
Valeant's dose of reality
FT News in Focus · Financial Times
December 2, 20159m 15s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Valeant was once considered a runaway success story, and one that upended the pharmaceutical sector. A series of crises engulfed the company in recent months, slashing nearly two thirds off its market valuation and forcing the company to tear up its forecasts for 2016. Correspondent David Crow explains. Read the full story at ft.com/valeant.Music: "Brand New Record!" by Steve Combs
Hosted on Acast. See acast.com/privacy for more information.